Please login to the form below
Haemato-oncology
This page shows the latest Haemato-oncology news and features for those working in and with pharma, biotech and healthcare.
EC approves Novartis’ Kymriah for advanced blood cancer
decreasing benefit,” said Catherine Thieblemont, head of the haemato-oncology unit of St-Louis Hospital.
Latest news
-
European biosimilars hit AbbVie’s Humira revenues in Q4
The company has several years to build up its other franchises, which includes its haemato-oncology therapies.
-
EU approval for Opdivo combo in renal cell cancer
which underscores the need for new treatments for this disease,” said Bernard Escudier, MD, ex-chairman of the genitourinary oncology committee, Institut Gustave Roussy. ... NSCLC). BMS recently announced a $74bn acquisition of Celgene, a move which
-
Dragonfly signs Celgene as partner for NK cell platform
Extends presence in haemato-oncology and solid tumours. Immuno-oncology start-up Dragonfly Therapeutics has bagged a $24 million licensing deal from Celgene for two cancer therapeutics based on natural killer ... That differentiates TriNKETs from other
-
Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma
BiTE will rival therapies from Bluebird, Celgene/Juno, J&J/Legend biotech
-
Regeneron’s early stage bispecific shows promise
Bispecifics and antibody drug conjugates will challenge CAR-Ts. The potentially revolutionary nature of CAR-Ts has made them the hottest properties in haemato-oncology in recent years, but a wave ... refractory follicular lymphoma patients," said Israel
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Deal Watch table for July 2013
485. Array BioPharma / Loxo Oncology. Multi-year licence and collaboration. Drug candidate (preclinical) discovery of small molecule drugs for oncology targets. ... 208. Talon Therapeutics / Spectrum Pharmaceuticals. Acquisition. Haemato-oncology
-
Pharma deals during July 2013
neurology and haemato-oncology, respectively.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- World Health Organization releases new road map for breast cancer
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Making new year resolutions that can also benefit others
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
- Europe’s cancer community publishes new report on transforming patient care
- Assessing the value of interim analyses in clinical trials
- Piloting a route to the biosimilars opportunities in Europe
- Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
